Protein Biomarker Producer Will Revolutionize Cardiovascular Research

Share Article

Lee BioSolutions Manufactures Myeloperoxidase and CRP, Key Prognostic Markers of Inflammation of Cardiovascular Disease

Lee BioSolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Myeloperoxidase isolated from Leukocytes and C-Reactive Protein from Pleural Fluid. The St. Louis-based biotechnology firm has developed a unique proprietary process to effectively and efficiently purify the Myeloperoxidase and C-Reactive Protein used in the prediction of Cardiovascular Disease. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components .

According to the Centers of Disease and Control, over 40% of all deaths in the United States are attributed to Cardiovascular Disease which means over 1 million of us die every year. Several risk factors are used by doctors to determine the risk of developing CVC but what better way to assess an individual than to be able to test and predict that they will have cardiovascular disease.

Lee’s new Myeloperoxidase and C-Reactive Protein production capabilities enables international diagnostics companies to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Cardiovascular research by supplying highly purified markers such as C-Reactive Protein and Myeloperoxidase . “ said Burton Lee, President of Lee Biosolutions . “ You will find the future of clinical diagnostics will utilize a greater number of combination of biomarkers to predict early clinical diagnosis of diseases as they are identified.”

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein(HDL), CkMB and Troponin, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit or call 314-968-1091.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Burton Lee
Visit website